VTV THERAPEUTICS ANNOUNCES COMPLETION OF ENROLLMENT IN PHASE 3 CATT1 STUDY OF CADISEGLIATIN IN TYPE 1 DIABETES (T1D)

Reuters · 2d ago

Please log in to view news